(Q48380933)

11 February 2018

title

Aripiprazole differentially regulates the expression of Gad67 and γ-aminobutyric acid transporters in rat brain (English)

1 reference

11 February 2018

Andrea Schmitt

2

0 references

author name string

Nina Peselmann

series ordinal

1

1 reference

11 February 2018

Peter J Gebicke-Haerter

series ordinal

3

1 reference

11 February 2018

Mathias Zink

series ordinal

4

1 reference

11 February 2018

publication date

12 September 2012

1 reference

11 February 2018

European Archives of Psychiatry and Clinical Neuroscience

published in

1 reference

11 February 2018

volume

263

1 reference

11 February 2018

issue

4

1 reference

11 February 2018

page(s)

285-297

1 reference

11 February 2018

https://scigraph.springernature.com/pub.10.1007/s00406-012-0367-y

exact match

0 references

cites work

Computational models of schizophrenia and dopamine modulation in the prefrontal cortex.

1 reference

https://api.crossref.org/works/10.1007%2FS00406-012-0367-Y

Neural circuitry models of schizophrenia: is it dopamine, GABA, glutamate, or something else?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-012-0367-Y

Unraveling monoamine receptors involved in the action of typical and atypical antipsychotics on glutamatergic and serotonergic transmission in prefrontal cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-012-0367-Y

Two classes of cortical GABA neurons defined by differential calcium binding protein immunoreactivities

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-012-0367-Y

Glial transporters for glutamate, glycine, and GABA: II. GABA transporters.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-012-0367-Y

GABA transporter GAT1 prevents spillover at proximal and distal GABA synapses onto primate prefrontal cortex neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-012-0367-Y

GABAergic interneurons: implications for understanding schizophrenia and bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-012-0367-Y

Cortical inhibitory neurons and schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-012-0367-Y

Alterations of cortical GABA neurons and network oscillations in schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-012-0367-Y

Downregulation of parvalbumin at cortical GABA synapses reduces network gamma oscillatory activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-012-0367-Y

Glutamatergic deficits and parvalbumin-containing inhibitory neurons in the prefrontal cortex in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-012-0367-Y

Alterations of hippocampal and prefrontal GABAergic interneurons in an animal model of psychosis induced by NMDA receptor antagonism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-012-0367-Y

A pharmacological model for psychosis based on N-methyl-D-aspartate receptor hypofunction: molecular, cellular, functional and behavioral abnormalities

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-012-0367-Y

Postnatal NMDA receptor ablation in corticolimbic interneurons confers schizophrenia-like phenotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-012-0367-Y

Altered cortical GABA neurotransmission in schizophrenia: insights into novel therapeutic strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-012-0367-Y

Treating impaired cognition in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-012-0367-Y

Disturbed function of GABAergic interneurons in schizophrenia: relevance for medical treatment?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-012-0367-Y

Conserved regional patterns of GABA-related transcript expression in the neocortex of subjects with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-012-0367-Y

Cortical deficits of glutamic acid decarboxylase 67 expression in schizophrenia: clinical, protein, and cell type-specific features

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-012-0367-Y

Expression of VGluT1 and VGAT mRNAs in human dorsolateral prefrontal cortex during development and in schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-012-0367-Y

Selective alterations in postsynaptic markers of chandelier cell inputs to cortical pyramidal neurons in subjects with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-012-0367-Y

Deficit and hemispheric asymmetry of GABA uptake sites in the hippocampus in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-012-0367-Y

GABA concentration in schizophrenia patients and the effects of antipsychotic medication: a proton magnetic resonance spectroscopy study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-012-0367-Y

Effects of chronic administration of antipsychotic drugs on GABA and other amino acids in the mesolimbic area of rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-012-0367-Y

Alterations in GABA-related transcriptome in the dorsolateral prefrontal cortex of subjects with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-012-0367-Y

Association with persistent neuroleptic-induced dyskinesia of regional changes in brain GABA synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-012-0367-Y

Glutamate decarboxylase messenger RNA in rat pallidum: Comparison of the effects of haloperidol, clozapine and combined haloperidol-scopolamine treatments

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-012-0367-Y

Differential effects of long-term treatment with clozapine or haloperidol on GABAA receptor binding and GAD67 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-012-0367-Y

Irreversible blockade of D2 dopamine receptors by fluphenazine-N-mustard increases glutamic acid decarboxylase mRNA in rat striatum

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-012-0367-Y

Clozapine, GABA(B), and the treatment of resistant schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-012-0367-Y

Clozapine and olanzapine treatment decreases rat cortical and limbic GABA(A) receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-012-0367-Y

Repeated phencyclidine administration alters glutamate release and decreases GABA markers in the prefrontal cortex of rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-012-0367-Y

Differential effects of long-term treatment with clozapine or haloperidol on GABA transporter expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-012-0367-Y

Effects of quetiapine on monoamine, GABA, and glutamate release in rat prefrontal cortex.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-012-0367-Y

Effects of zotepine on extracellular levels of monoamine, GABA and glutamate in rat prefrontal cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-012-0367-Y

Associations between plasma levels of 3-methoxy-4-hydroxyphenylglycol (MHPG) and negative symptoms or cognitive impairments in early-stage schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-012-0367-Y

Reduction of brain gamma-aminobutyric acid (GABA) concentrations in early-stage schizophrenia patients: 3T Proton MRS study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-012-0367-Y

Elevated prefrontal cortex γ-aminobutyric acid and glutamate-glutamine levels in schizophrenia measured in vivo with proton magnetic resonance spectroscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-012-0367-Y

Partial agonists in schizophrenia--why some work and others do not: insights from preclinical animal models.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-012-0367-Y

In vivo actions of aripiprazole on serotonergic and dopaminergic systems in rodent brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-012-0367-Y

A systematic review of aripiprazole--dose, plasma concentration, receptor occupancy, and response: implications for therapeutic drug monitoring

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-012-0367-Y

The neurocognitive effects of aripiprazole: an open-label comparison with olanzapine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-012-0367-Y

Unique pharmacological profile of aripiprazole as the phasic component buster

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-012-0367-Y

Aripiprazole protects cortical neurons from glutamate toxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-012-0367-Y

Chronic treatment with aripiprazole induces differential gene expression in the rat frontal cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-012-0367-Y

Differential expression of glutamate transporter genes after chronic oral treatment with aripiprazole in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-012-0367-Y

Effects of chronic oral treatment with aripiprazole on the expression of NMDA receptor subunits and binding sites in rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-012-0367-Y

5-HT1A receptor agonists enhance pyramidal cell firing in prefrontal cortex through a preferential action on GABA interneurons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-012-0367-Y

Reduced expression of GABA transporter GAT3 in helpless rats, an animal model of depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-012-0367-Y

Retrograde degeneration of thalamic neurons in the mediodorsal nucleus after neonatal and adult aspiration lesions of the medial prefrontal cortex in the rat. Implications for mechanisms of functional recovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-012-0367-Y

Effects of neonatal mediodorsal thalamic lesions on structure and function of the rat prefrontal cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-012-0367-Y

Serotonin 1A receptors in human and monkey prefrontal cortex are mainly expressed in pyramidal neurons and in a GABAergic interneuron subpopulation: implications for schizophrenia and its treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-012-0367-Y

Modulation of the activity of pyramidal neurons in rat prefrontal cortex by raphe stimulation in vivo: involvement of serotonin and GABA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-012-0367-Y

Structural synaptic elements are differentially regulated in superior temporal cortex of schizophrenia patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-012-0367-Y

Effects of aripiprazole, olanzapine, and haloperidol in a model of cognitive deficit of schizophrenia in rats: relationship with glutamate release in the medial prefrontal cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-012-0367-Y

Olanzapine, but not aripiprazole, weight-independently elevates serum triglycerides and activates lipogenic gene expression in female rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-012-0367-Y

Regulation of cortical and subcortical glutamate receptor subunit expression by antipsychotic drugs

21 January 2018

1 reference

12 December 2020

Chronic treatment with a classical neuroleptic alters excitatory amino acid and GABAergic neurotransmission in specific regions of the rat brain

1 reference

12 December 2020

BL-1020, an oral antipsychotic agent that reduces dopamine activity and enhances GABAA activity, for the treatment of schizophrenia

1 reference

12 December 2020

Astrocyte decrease in the subgenual cingulate and callosal genu in schizophrenia.

1 reference

12 December 2020

The development of the rat prefrontal cortex. Its size and development of connections with thalamus, spinal cord and other cortical areas

1 reference

12 December 2020

Effect of novel atypical antipsychotic, blonanserin, on extracellular neurotransmitter level in rat prefrontal cortex

1 reference

12 December 2020

Differential regulation of mRNA levels encoding for the two isoforms of glutamate decarboxylase (GAD65 and GAD67) by dopamine receptors in the rat striatum

1 reference

12 December 2020

Neuroplasticity of excitatory and inhibitory cortical circuits in schizophrenia.

1 reference

12 December 2020

Expression of parvalbumin and glutamic acid decarboxylase-67 after acute administration of MK-801. Implications for the NMDA hypofunction model of schizophrenia

1 reference

12 December 2020

Qualitative and quantitative comparison of the prefrontal cortex in rat and in primates, including humans

1 reference

12 December 2020

Traditional and new antipsychotic drugs differentially alter neurotransmission markers in basal ganglia-thalamocortical neural pathways

1 reference

12 December 2020

Assessing and maximizing the safety and tolerability of antipsychotics used in the treatment of children and adolescents

1 reference

12 December 2020

Modeling interneuron dysfunction in schizophrenia

1 reference

12 December 2020

Expression of glutamic acid decarboxylase mRNA in striatum and pallidum in an animal model of tardive dyskinesia

1 reference

12 December 2020

The neurobiology of cognition in schizophrenia.

1 reference

12 December 2020

The vesicular GABA transporter, VGAT, localizes to synaptic vesicles in sets of glycinergic as well as GABAergic neurons.

1 reference

12 December 2020

The nature of dopamine dysfunction in schizophrenia and what this means for treatment

1 reference

12 December 2020

Typical and atypical antipsychotic drugs increase extracellular histamine levels in the rat medial prefrontal cortex: contribution of histamine h(1) receptor blockade

1 reference

12 December 2020

Aripiprazole differentially affects mesolimbic and nigrostriatal dopaminergic transmission: implications for long-term drug efficacy and low extrapyramidal side-effects

1 reference

12 December 2020

Amygdalo-entorhinal inputs to the hippocampal formation in relation to schizophrenia

1 reference

12 December 2020

GABAergic modulation of striatal peptide expression in rats and the alterations induced by dopamine antagonist treatment

1 reference

12 December 2020

10.1007/S00406-012-0367-Y

Identifiers

DOI

1 reference

11 February 2018

1 reference

11 February 2018